EP 1082122 A4 20030409 - ISOFLAVONOIDS FOR TREATMENT AND PREVENTION OF MIGRAINE HEADACHES
Title (en)
ISOFLAVONOIDS FOR TREATMENT AND PREVENTION OF MIGRAINE HEADACHES
Title (de)
ISOFLAVONOIDE ZUR BEHANDLUNG VON MIGRÄNEKOPFSCHMERZEN
Title (fr)
ISOFLAVONOIDES UTILES DANS LE TRAITEMENT ET LA PREVENTION DE MAUX DE TETE DU TYPE MIGRAINE
Publication
Application
Priority
- US 9911532 W 19990525
- US 8548098 A 19980527
Abstract (en)
[origin: WO9961028A1] A method of treating or preventing, in a person, one or more symptoms of migraine headaches, said method comprising oral administration or by a transdermal delivery system or patch to said person a composition comprising one or more purified isoflavonoids selected from the group consisting of genistein, daidzein, biochanin A, formononetin, O-desmethylangolensin, glycitein, equol and dihydrodaidzein and their conjugates.
IPC 1-7
IPC 8 full level
A61K 31/352 (2006.01)
CPC (source: EP)
A61K 31/352 (2013.01)
Citation (search report)
- [X] WO 9808503 A1 19980305 - NOVOGEN RES PTY LTD [AU], et al
- [PX] EP 0906761 A2 19990407 - ARCHER DANIELS MIDLAND CO [US]
- [Y] HIRAKURA K ET AL: "Phenolic glucosides from the root of Pueraria lobata", PHYTOCHEMISTRY, PERGAMON PRESS, GB, vol. 46, no. 5, November 1997 (1997-11-01), pages 921 - 928, XP004293503, ISSN: 0031-9422
- [Y] KITAZONO TAKANARI ET AL: "Role of tyrosine kinase in serotonin-induced constriction of the basilar artery in vivo.", STROKE, vol. 29, no. 2, February 1998 (1998-02-01), pages 494 - 498, XP002229783, ISSN: 0039-2499
- See references of WO 9961028A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9961028 A1 19991202; AU 4204099 A 19991213; CA 2333556 A1 19991202; EP 1082122 A1 20010314; EP 1082122 A4 20030409
DOCDB simple family (application)
US 9911532 W 19990525; AU 4204099 A 19990525; CA 2333556 A 19990525; EP 99925828 A 19990525